[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@RudyResearch Avatar @RudyResearch Rudy Research

Rudy Research posts on X about $abvx, $ptgx, $abbv, $xbi the most. They currently have XXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XXXXX%

Social topic influence $abvx #13, $ptgx 15.79%, $abbv #73, $xbi 10.53%, $bbc 10.53%, $jnj 10.53%, $tern #3, abbv 10.53%, just a 5.26%, lack of XXXX%

Top accounts mentioned or mentioned by @taintslapp12283 @pcmbio @pcm_bio @allah @aamortazavi @houndcl @tallnfat @bigchodu

Top assets mentioned Protagonist Therapeutics, Inc (PTGX) AbbVie Inc (ABBV) Bitcoin Incognito (XBI) Johnson & Johnson (JNJ) Terns Pharmaceuticals, Inc. Common Stock (TERN) SPDR S&P XXX ETF Trust (SPY) Cogent Biosciences, Inc. Common Stock (COGT) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Soleno Therapeutics, Inc. Common Stock (SLNO)

Top Social Posts

Top posts by engagements in the last XX hours

"A big issue in pharma biz is doctors are humans and being a doctor sounds magical - but its just a fancy title X to X for most in that biz. Big pharma marketing plays a huge role in decisions patients lack of knowledge and sophistication as well. $XBI $BBC"
X Link 2025-11-24T20:05Z XXX followers, XXX engagements

"$xbi $bbc are basically in their bull market cycle. Historically these track relatively close to but below $SPY $QQQ performance - but have really under performed post 2021. Bull market in non-cyclical firms patent cliffs driving innovation m&a underlying valuations. Explosive"
X Link 2025-11-26T17:05Z XXX followers, XXX engagements

"@AAMortazavi Look at how $jnj went with $ptgx for an oral and its just an IL-23 oral. Everyone just wants the 'free lunch' in this industry. And people wonder why most big pharmas have never really breached 500b+ mcaps"
X Link 2025-12-03T19:25Z XXX followers, XXX engagements

"@houndcl $abbv talking the book with their classic positioning of 'we are here first and have the most real in market data with good safety and disease remission'. Someone's gotta pay for that $ptgx and $abvx smashing the rinvoq 2031 extension"
X Link 2025-12-03T18:58Z XXX followers, XXX engagements

"$tern is a CML monster starting a PHASE X in 2026 with no reason to raise cash. CEO says she is wanting to commercialize (we will see lol). But they also have the metabolic portfolio which was trash - though someone would buy this and get that as a yolo bonus tbh"
X Link 2025-12-08T20:47Z XXX followers, 1229 engagements

"@PCM_bio $abbv talking as defensive as possible because they know $abvx has a straight up rinvoq killer"
X Link 2025-12-03T18:34Z XXX followers, XXX engagements

"$abbv out here talking their book on $abvx. All they can do is target that $abvx is novel and therefore should be feared. And that since skyrizi/rinvoq are older in market - they're better due to long term data (that just matches the clinical trials lol)"
X Link 2025-12-03T19:08Z XXX followers, 4374 engagements

"$abvx not getting bought out now. Furus killed it. $jnj buying $ptgx. Long $tern $gpcr $cogt and sleep"
X Link 2025-12-10T22:24Z XXX followers, 3957 engagements

"$nktr $pyxs $rzlt WHERE ARE THE DATA CMON"
X Link 2025-12-08T21:23Z XXX followers, 1754 engagements

"how was good news for $rytm supposed to not drop $slno"
X Link 2025-12-11T16:59Z XXX followers, XXX engagements